Anagenics (AN1, Cellmid Limited) is an Australian Beauty, health and wellness video with a portfolio of skin, hair and wellness brands.
Prior to rebranding in 2021, Anagenics was a biotech sciences accelerator for indication of multiple diseases. It operated mainly through its wholly owned subsidiaries, Advangen Limited, Kinera and Lyramid Limited, which develop and market innovative novel therapies and diagnostic tests for inflammatory and fibrotic diseases, cancer, ischemic diseases of the heart, and hair loss.
The company holds global intellectual properties relating to novel targets midkine and FGF5.